Miami Cancer Institute Research
@MiamiCancerInst
Followers
834
Following
2K
Media
356
Statuses
1K
Providing quality cancer care in South Florida and aiming for innovative research excellence, part of @BHCancerCare | @BaptistHealthSF
South Florida
Joined October 2022
RT @BaptistHealthSF: Thyroid cancer is often highly treatable, but every journey looks different. From diagnosis to survivorship, here’s wh….
curetoday.com
Learn about diagnosis, explore your thyroid cancer treatment options and find practical advice for managing side effects and living well after treatment.
0
1
0
💡 Dr. Naiara Braghiroli delivered an insightful presentation at the Second Annual Miami Skin Cancer Symposium, guiding clinicians on how to identify suspicious lesions and determine when to perform or request a biopsy. #MedEd #skincancer
0
0
4
RT @BaptistHealthSF: Join us for the Baptist Health Biomedical Research Symposium where experts will share insights on:. ✅ Advancing trans….
0
3
0
RT @BaptistHealthSF: Congrats to the @FIUMedicine Class of 2029! Your white coat represents more than a uniform — it’s a promise to lead wi….
0
4
0
RT @MikeChuongMD: Check out our multi-center retrospective analysis of ablative 5-fraction SMART (@MiamiCancerInst) and 15/25-fraction HART….
mdpi.com
Background: Radiation dose escalation for locally advanced pancreatic cancer (LAPC) using stereotactic magnetic resonance (MR)-guided online adaptive radiation therapy (SMART) or computed tomography...
0
18
0
RT @FIUMedicine: We're excited to introduce the chairs of our new clinical departments. This reflects our commitment to academic excellence….
0
2
0
RT @MPN_Hub: CONGRESS | #EHA2025 | PRESENTATION. Firas El Chaer @FirasElChaer @MiamiCancerInst presented findings from a phase I/II study e….
0
4
0
RT @AML_Hub: CONGRESS | #EHA2025 | PRESENTATION.@GuentherKoehne @MiamiCancerInst shares preliminary results from the phase I/II VBP101 tria….
0
4
0
RT @BHCancerCare: Dr. Murugesan Manoharan, @MiamiCancerInst's chief of urologic oncology surgery, highlighted evidence-based advances in pr….
0
7
0
💡@RohanGarjeMD breaks down the latest systemic therapy recommendations for metastatic castration-resistant prostate cancer (mCRPC). Insightful takeaways for clinicians navigating evolving standards of care. 📖 Read via @physicianswkly: #ProstateCancer.
physiciansweekly.com
A review of 22 trials led the American Society of Clinical Oncology (ASCO) to issue updates to its mCRPC systemic therapy guideline.
0
1
2
RT @BHCancerCare: June is Cancer Survivors Month, a time to honor strength, resilience, and life beyond treatment. At Baptist Health Cancer….
baptisthealth.net
National Cancer Survivors Day is June 1, 2025, a time to honor the strength, resilience, and courage of cancer survivors. Baptist Health Miami Cancer Institute is committed to continuous care,...
0
1
0
💡@DrReshmaMahtani discusses pivotal #ASCO25 presentations that may shape #breastcancer standard of care via @CancerNetwrk #bcsm.
cancernetwork.com
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
0
1
3
RT @Sarbaji85064063: From brainstorming sessions in the clinic to the @ASCO stage—what a journey it’s been! Watching my mentees present at….
0
5
0
We’re honored to celebrate Zouina Sarfraz, MBBS (@ZouinaS), recipient of a 2025 @ConquerCancerFd Merit Award for her rigorous evaluation of SRN risk in HER2+ breast cancer brain mets. Her findings reveal a consistent increase in SRN with concurrent ADC + RT—key data for future
0
0
4
RT @OncNewsCentral: #ASCO25 GAIN Trial: Neoadjuvant #Gemcitabine/cisplatin nearly doubled median OS to 27.8 months vs 14.6 months with adju….
oncologynewscentral.com
Final results from the phase 3 GAIN trial suggest that neoadjuvant chemotherapy may improve survival in biliary tract cancer.
0
1
0
RT @OncLive: In this "Beat the Clock" segment, @BrainTumorDoc of @MiamiCancerInst, goes #OntheClock ⏱️ with Dr Chandler Park of @mednewswee….
0
4
0
📍Live from #ASCO25: Our team is energized and ready for today’s powerful plenary sessions—driving forward the breakthroughs that will redefine cancer care. 🍍💡
0
1
11
RT @BaptistHealthSF: We’re proud to see @MiamiCancerInst researchers paving the way for more inclusive databases and equitable access to pr….
0
2
0
Congratulations to Dr. Sarbajit Mukherjee (@Sarbaji85064063), our new Chief of GI Medical Oncology, for presenting an oral abstract on neoadjuvant strategies in biliary tract cancer. 🍍👏. We look forward to advancing these approaches in future clinical trials. #ASCO25
0
0
4
💡 Dr. Arelis Martir-Negron presents new research on the prevalence and diversity of BRCA1/2 pathogenic variants in South Florida’s Hispanic population. 📊 5.2% carried a BRCA1/2 P/LP variant—most in BRCA2 (68.2%)—including unique variants in patients of Cuban, Nicaraguan &
0
0
2